To ensure the quality and safety of medical services in primary healthcare institutions, China’s National Health Commission (NHC) and other relevant authorities issued a notice on 1 April 2026, outlining a three-year nationwide action.

Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Recently, Genalive, a joint venture between BGI Almanahil Health for Medical Services (a wholly owned subsidiary of BGI Genomics) and Tibbiyah Holding (a wholly owned subsidiary of Saudi Al Faisaliah Group), opened its independent clinical laboratory.

Qiagen on Thursday announced a systematic review and publication of the clinical relevance of test values from its QuantiFeron-TB Gold Plus TB1 and TB2 blood collection tubes.

Breast Cancer Canada said on Thursday that it has launched a new grant program in collaboration with AstraZeneca Canada and Illumina.

On June 15, 2023, the inaugural meeting of Institute of Bioinformatics of Shanghai Academy of Experimental Medicine (hereinafter referred to as "Institute of Bioinformatics") and Gene Sequencing Bioinformatics Research Summit Forum was held in Intercontinental Hotel in Jing'an, Shanghai. Ltd.

Eli Lilly and Verve Therapeutics on Thursday said they have entered into an exclusive research collaboration to advance a preclinical gene-editing therapy for atherosclerotic cardiovascular disease (ASCVD) into the clinical stage.

MGI Tech, a Shenzhen, China-based firm focused on the development and distribution of sequencing instruments and reagents, on Wednesday announced that it has signed a licensing agreement with Xpress Genomics.

Seegene Inc. (KQ096530), a leading South Korean company which provides a total solution for PCR molecular diagnostics, announced an agreement with Werfen, a worldwide leader in Specialized Diagnostics, to advance discussions on the expansion of its current collaboration for the Spanish and Portuguese marketplaces through Seegene's OneSystem™ Business.

On June 9, a launching ceremony was held for the Stago Medical Device Factory. On the same day, the opening ceremony of DiaSorin’s Baoshan factory was held.

Becton, Dickinson and Company (BD) has globally introduced the new automated instrument, the BD FACSDuet Premium Sample Preparation System, for cellular diagnostic applications.

The National Institutes of Health (NIH) has awarded a $4.6 million contract to Sorrento Therapeutics to develop an in vitro diagnostic testing platform for biodefense, antimicrobial-resistant infections, and emerging infectious diseases, the firm said Tuesday.